Online article for Non-subscribers

Pay per view

Heterocycles has a pay-per-view service for Non-subscribers.
You will be able to directly purchase the full text article through PayPal.
Your purchased Paper can be downloaded after the payment is completed.
An e-mail will be sent the URL to download the paper.
If you have any questions, please contact:

Price: ¥ 4,400 (Yen only)
Period: This Article can be accessed for 7 days.

Paper | Regular issue | Vol 98, No. 9, 2019, pp.1200-1214
Published online, 30th September, 2019
DOI: 10.3987/COM-19-14144
A Facile Synthesis, Docking Study and Antitumor Activity of Some Furan-Chalcone and Furylpyrazole Hybrids

Ahmed S. Radwan*

*Chemistry, Taif University, Taif 21995, Saudi Arabia


Several new furan-based heterocycles were prepared by the reaction of furan-chalcone derivative 1 and/or furylpyrazole thioamide derivative 2 with various electrophilic reagents (e.g. 4-anisaldehyde, thiosemicarbazide, dimethylformamide dimethyl acetal, phenyl isothiocyanate, N-cyanoacetyl-pyrazole and nitrous acid). Spectroscopic and elemental analyses were applied to emphasize the structures of these furan containing scaffolds. The newly constructed furan-chalcones and furylpyrazoles were tested for their cytotoxicity on hepatocellular cancer (HepG-2), breast cancer (MCF-7) and colon cancer (HCT-116). The pyrazole scaffold 10 exhibited the highest cytotoxic effect against the tested cell lines HepG2 (IC50 7.36±0.6 μg/mL), HTC-116 (IC50 8.14±0.8 μg/mL), and MCF-7 (IC50 12.16±0.8 μg/mL), compared with the standard anticancer drug Doxorubicin (DOX). Binding mode of the most active compound 10 was illustrated using docking methods that were processed in the same co-crystallographic inhibitor binding site, docking was revealed same interaction of compound 10 analogous to the binding of native inhibitor.